Treatment of Deep Vein Thrombosis with Continuous IV Infusion of LMWH: A Retrospective Study in 32 Children
- PMID: 22084672
- PMCID: PMC3195315
- DOI: 10.1155/2011/981497
Treatment of Deep Vein Thrombosis with Continuous IV Infusion of LMWH: A Retrospective Study in 32 Children
Abstract
Thirty-two consecutive children aged 0-18 years with VTE treated with LMWH administered as a continuous infusion (CI) were identified at the Children's University Hospital Brno. The treatment led to at least partial resolution of the thrombus within two weeks in 85% of patients. There were no adverse events or increased bleeding reported in any patients. No recurrences were observed during a followup period of 6 months. Although continuous infusion should not replace subcutaneous (SC) administration of LMWH, CI appeared to be safe and efficient and may provide an alternate method of administering LMWH in a subset of the paediatric population where SC administration may not be feasible. Further prospective studies are needed to support the promising findings of our pilot clinical observation.
Figures
References
-
- Hirsh J. Drug therapy: heparin. The New England Journal of Medicine. 1991;324(22):1565–1574. - PubMed
-
- Collins R, Scrimgeour A, Yusuf S, Peto R. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery. The New England Journal of Medicine. 1988;318(18):1162–1173. - PubMed
-
- Castaman G, Rodeghiero F, Dini E. Thrombotic complications during L-asparaginase treatment for acute lymphocytic leukemia. Haematologica. 1990;75(6):567–569. - PubMed
-
- Bernstein D, Coupey S, Schoenberg SK. Pulmonary embolism in adolescents. American Journal of Diseases of Children. 1986;140(7):667–671. - PubMed
LinkOut - more resources
Full Text Sources